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During cellular remodeling that accompanies cornification 
of epidermal cells, the highly phosphorylated protein, profi-
lag grin, is dephosphorylated and proteolytically cleaved to 
filaggrin, the keratin matrix protein. Using rat filaggrin 
phosphorylated by bovine casein kinase II (CK II) as a sub-
strate , we have partially purified a phosphatase from rat epi-
dermis which dephosphorylates rat profilaggrin in vitro. 
Anion exchange, hydroxylapatite, and gel filtration chroma-
tography yielded a lOO-fold purification of phosphatase from 
a low-salt extract. Further purification led to loss of activity; 
therefore, only the partially purified phosphatase was charac-
terized. Two forms of the phosphatase, with molecular 
weights of approximately 170 and 40 kDa, were resolved 
during gel filtration. The 170-kDa form could be converted 
to the 40-kDa form in the presence of dithiothreitol. Both 
D ifferentiation of epidermal cells is a multistep pro-cess resulting in the formation of cornified cells filled with an ordered array of keratin intermediate filaments embedded in a matrix and surrounded by the cornified cell envelope (see Ref 1 for review). 
This occurs in discrete morphologically distinguishable steps be-
ginning when the dividing basal cells release from the basement 
membrane to become first spinous, then granular cells, followed by 
the massive cell remodeling that results in the cornified cells that are 
eventually sloughed at the surface. In the spinous cells, a new set of 
keratin filaments [2] and the envelope precursors [3] are synthesized, 
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Abbreviations: 
bis-tris: bis (2-hydroxyethyl) imino-tris-(hydroxymethyl) methane 
BSA: bovine serum albumin 
CK II: casein kinase II 
DE52: diethylaminoethyl cellulose 
OTT: dithiolthreitol 
EDTA: disodium ethylenediaminetetraacetate 
HE PES: N -2-hydroxyethylpiperazine-N' -2-ethanesulfonic acid 
HPLC: hi gh pressure liquid chromatography 
PAGE: polyacrylamide gel electrophoresis 
PBS: phosphate buffered sa line 
PMSF: Phenylmethylsulfonyl fluoride 
pNPP: para-nitrophellyl phosphate 
SDS: sodium dodecyl su lfate 
TPCK: tosylphenylalanine chloroketone 
TFA: trifluoroacetic acid 
Tris: Tris-(hydroxymcthyl) aminomcthane 
forms had pH optima of 6.6, and were strongly inhibited by 
N aCI (50% inhibition at 35-40 mM). Neither form hydro-
lyzed para-nitrophenylphosphate or dephosphorylated 
casein or the synthetic peptide arg3-glu3-thr-glu3' which 
were phosphorylated by casein kinase II. The two forms were 
similarly inhibited by known inorganic phosphatase inhibi-
tors, with 22%-36% inhibition by 0.1 mM Na+ /K+ tartrate, 
55%-60% inhibition by 0.1 mM NaF, and 75% inhibition by 
0.1 m.M N a pyrophosphate. Para-chloromercuribenzoate 
also inhibited the activity, suggesting that reduced thiols may 
be important in catalysis. One mM calcium chloride altered 
the activity in a complex manner depending on the pH, 
suggesting a possible role for calcium in regulating enzyme 
activity. ] Invest Dermatol 91 :553 -559, 1988 
followed by the appearance of nonmembrane-bound keratohyalin 
granules in the granular cells. Formation of the cornified cell in-
volves hydrolysis or breakdown of"cellular organelles [4], dehydra-
tion, formation of the cornified cell envelope [5], and rearrange-
ment of the keratin filaments into an orderly, densely packed 
aggregate [4]. The latter aggregation appears to be caused by fi lag-
grin, a histidine-rich basic protein which is synthesized as a high 
molecular weight precursor called profilaggrin, and deposited in the 
keratohyalin granules (see Ref 6 for review). 
Profilaggrin is highly phosphorylated [7,8] on serine residues [9] 
and contains many copies of filaggrilJ. joined by linker peptides [10]. 
During the conversion of a granular cell to a cornified cell, profilag-
grin is dephosphorylated and proteolytically processed to release 
filaggrin "[11 -13] in a sequence of events that must be carefully 
timed to avoid premature aggregation of the keratin filaments. This 
processing of profilaggrin is correlated with the dispersal of the 
keratohyalin granules to form the matrix protein of the cornified 
cell. The specific enzymes involved in the phosphorylation of pro-
filaggrin and its subsequent modification to filaggrin are under in-
vestigation. Sequence analysis of the phosphopeptides of mouse 
profilaggrin shows that the phosphoserines are located on the 
amino-terminal side of acidic residues [10]. This type of site suggests 
that a kinase with a substrate specificity similar to casein kinase II 
(CK II) is involved [14], a hypothesis supported by the in vitro 
phosphorylation of filaggrin by CK II [15,16] . 
Dephosphorylation may be the essential first step in profilaggrin 
processing, which must involve one or more protein phosphatases. 
However, protein phosphatases of epidermis have not been exten-
sively investigated. Although epidermal acid phosphatases that hy-
drolyzed small synthetic substrates, e.g., para-nitrophenyl phos-
phate (pNPP), have been reported (17 -19), but only in the study by 
Hara et al [1 9] were these shown to act upon protein substrates. The 
proteins tested, phosphocasein and phosvitin, are not found in epi-
dermis. Our aim was to identify an epidermal protein phosphatase 
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capable of dephosphorylating profilaggrin. Because profilaggrin is 
insoluble, we used fila ggrin phosphorylated in vitro by CK II as a 
substrate analog for profilaggrin. Unlike profilaggrin, it is soluble, 
readily avail ab le, and easily purified. Previous studies have demon-
strated th at phosphorylation of filaggrin by this method occurs on 
sites identical to those phosphorylated in vivo [10,16]. Usin g this 
substrate, we found two forms of protein phosphatase, which appear 
identical except in molecular weight, and the initial characteriza-
tion of these enzymes is described. 
METHODS 
Purification of Phosphatase The skins of 30 three-day-old 
Sprague-Dawley rats were floated dermis down on 0.25% trypsin in 
H ank's balanced salt solution (Gibco, Grand Island , NY) for 8-12 h 
at 10°C. After rinsing in 0.1 % soybean trypsin inhibitor (Sigma, St. 
Louis, MO) in phosphate-buffered saline (PBS) , then in PBS alone, 
the dermis and epidermis cou ld be separated. In some cases epi-
dermis was separated by treatment with 10 mM EDTA in PBS at 
50 °C, with 1 M NH4S04 on ice, or by brief exposure to microwave 
radiation [20]. Epidermis was separa ted, weighed, and homoge-
ni zed briefl y in a loose fittin g ground glass homogenizer in 50 mM 
Tris, 0.1 mM EDTA, 0.1% Triton X-I00, 0.1 mg/ml aprotinin 
(Boehringer Mannh eim, Indianapolis, IN), pH 7.0 (0.4 g tissue/mL 
buffer). The tissue was difficult to homogenize in this buffer, but 
adeq uate disruption was obtained after stirring at 4°C for 8 h. T he 
homogenate was centrifuged at 27,000 X g for 30 min , th en the 
supernatant filtered through glass wool and a 22 fJ. filter (MiJlipore, 
Bedford, MA) . Supernatant was applied to DE 52 (1 .0 cm X 16 cm, 
Whatman, Clifton, NJ), equilibrated in 50 mM Tris, 0.1 mM 
EDTA, 0.1 % Triton X-IOO, pH 7.0 (buffer A) . Phosphatase activity 
eluting from the DE52 column with a N aCI gradient (limit buffer, 
0.5 M N aC I in buffer A; total vo lume of gradient 60 mL) was 
appli ed, without desa lting, to a hydroxylapatite column (1.0 cm X 
6.5 cm, BioRad, Richmond, CA), equilibrated in buffer A, and 
eluted w ith a sodium phosphate gradient (limit buffer, 0.4 M so-
dium phosphate in buffer A; total gradient, 25 mL) . The pooled 
fractions with phosphatase activity were th en simultaneously de-
salted and purified further by chronutography on Sephacry l S200 
(1.5 cm X 90 cm, Pharmacia, Piscataway, NJ), equilibrated in 
buffer A. 
Preparation ofPhosphofilaggrin Substrate Bovine heart CK 
II was a ge nerous gift of M.D. Mamrack (Wright State University, 
Dayton, OH). Rat filaggrin, purified by the method of Dale et al 
[21] was phosphorylated by incubation of 1 mg fi laggrin with 7.1 
fJ.g CK II in 15 mM bis-tris, 10 111M M gCI2' 2.5 fJ.M ATP, 0.2 M 
N aC I, pH 7.0, with 50 fJ.Ci [32P]_ATP in 5 mL. Phosphofilaggrin 
was adj usted to pH 2.5 with phosphoric acid and repurified by 
HPLC (Model 5000, Varian, Palo Alto, CA) on a Partisil 5 ODS-3 
(Whatman, C lifton , NJ) reverse- phase co lum n equilibrated in 
0.1 % trifluoroacetic acid (TFA) and eluted with a linear gradient 
(1 %/min ; 2 mL/ min; limit buffer, acetonitrile/0.8% TFA). The 
phosphofilaggrin eluted between 12% and 15% acetonitrile. The 
acetonitril e/TFA was removed by lyophili zation, and th e phospho-
filaggrin dissolved in water for dilution into the phosphatase assay. 
In a typica l preparation, 900 fJ. g protein was recovered with 3.3 X 
107 dpm incorporated (3.6 mol phosphate/mol fila ggrin). Phos-
phorylated casein (#C-4765, Sigma, St. Louis, MO) and a synthetic 
phosphopeptide (argrglurthr(P)-glu3' Peninsula , Belmont, CA) 
were prepared in the same manner. Profi laggrin labeled in vivo with 
[32PJ-phosphate was prepared by the method of Resing et al [1 OJ. 
Phosphatase Assay Dephosphory lation of substrates was mea-
sured as 32p; released after precipitat ion by ethanol. Enzyme aliquots 
were incubated at 38 °C in 50 fJ.L 50 mM bis-Tris, pH 6.8, with 
2-20 Ilg of phosphofilaggrin or phosphocasein or with 100 fJ.g 
phosphopeptide. After incubation for 30 min at 37°C, 200 fJ.g bo-
vine serum albu min (BSA) was added, sa mpl es were transferred to 
ice, 0.25 mL cold ethanol was added, and sa mples were left on ice 
for 30 min. Precipitated protein was removed by centrifguation in a 
microfuge (Beckman, Palo Alto, CA) for 3.5 min, and 200 fJ.L of th e 
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supernatant was added to 6 mL Aquaso l (NEN, Boston, MA) and 
counted. The precipitated proteins were ana lyzed by SDS-PAGE by 
the method of Laemmli and th e dried gel exposed to X-omat film 
(Kodak, Rochester, NY) to confirm that the phosphate released 
was not due to proteolytic activ ity. In some cases the amount of 
phosphofilaggrin was increased to 5 {1g and no BSA was added as a 
ca rrier, beca use the presence ofBSA interfered with the detection of 
th e phosphofi laggrin on the stained gel. 
Acid phosphatase activity using pNPP was measured using a 
Sigma assay kit (citrate buffer, pH 4.8). pNPP hydrolytic activity at 
neutral pH was measured with the same kit, except that 100 nU\1. 
bis-.tris (pH 7.0) was used in place of th e citrate buffer. The pH 
optIma of the two forms of phosphatase were measured using 
50 mM sodium citrate (pH 4.8 to 5.7), bis-tris (pH 5.9 to 6.6) 
HEPES (pH 6.8 to 7.4), or Tris (pH 7.6 to 8.0). ' 
Dephosphorylation of profilaggrin In vivo labeled (32P]-profi_ 
laggrin was prepared as described in Resing et al [10] by injecting 
[32P]-phosphate subcutaneously into newborn mice with subse_ 
quent extraction of the epidermis in 1 M NaSC N , 10 fJ.g / mL PMSF 
and o-phenanthraline, 10 mM EDTA, 50 111M HEPES, pH 6.8 
(300 fJ.L for each epidermis). At least 90% of the [32P]-phosphate in 
this ex tract is on profilaggrin [10,12] . Phosphatase (100 fJ.L in buffer 
A) was diluted with 390 fJ.L water, and the reaction was inititated by 
adding 10 fJ.L of the N aSCN extract containing profilaggrin. One 
hundred microliters of buffer A without phosphatase was used in 
the control s. After incubation at 37°C for 30 min, 20 fJ.g BSA Was 
added and the protein was precipitated with 2 mL ethanol at 
- 20 °C. Samples were centrifuged in a microfuge and 1.5 mL of the 
supernatant was counted. 
Dephosphorylation of Tryptic Peptides ofFilaggrin Tryptic 
di gests of phosphofilaggrin were prepared by incubating 20 J-lg 
phosphofilaggrin with 0.2 fJ.g TPCK-treated trypsin (2x crystal_ 
lized, Worthington, Freehold , NJ) (pH 8.0) at 38°C (25 ilL fina l 
volume). After 1 h, 10 fJ.g soybean trypsin inhibitor (Sigma, St. 
Louis, MO) was added to inhibit the trypsin. After incubation of the 
di gested phosphofilaggrin with phosphatase, th e reaction mixtures 
were acidified with HCI to pH 2-2.5 and applied to a Synchropak 
RP-P (C 18) HPLC column equilibrated in 0.1 % TFA/H20 . The 
peptides were eluted with a gradient into 0.08% TFA/acetonitrile. 
Dephosphorylation of the tryptic di gest was assessed by measuring 
th e 32p; that appeared in th e breakthrough pool of a Synchropak 
RP-P (C 18, Synchrom, Lafayette, IN) column which bound th e 
phosphopeptides and did not bind inorga nic phosphate. 
RESULTS 
Purification of Profilaggrin Phosphatase Demonstration of 
profilaggrin phosphatase activity was most successfu l when 3-d old, 
rather than 1- 01' 2-d old, rats were used as a source. Epidermis 
prepared by flotation on trypsin solutions gave reproducible results 
during se ven prepara tions. The duration of tryptic treatment solu-
tions required to separate the skins varied from 6 to 18 h, but this did 
not produce any detectable difference in th e resulting phosphatase. 
Epidermis prepared by heating in EDTA, by hea ting in a microwave 
by the method of Mufson et al [20] , or by treatment with cold 
{NH4hS04 showed no phosphatase activity. The extraction buffer 
used (with a low sa lt concentration and Triton X- IOO) left most of 
th e ce llular protein in th e pellet, thus effecting a significant purifi-
cation. Although th e phosphatase could also be extracted in the 
absence of Triton , the enzyme was more labi le under these condi-
tions. Triton was therefore included ill -a ll buffers. 
T he subsequ ent three-step purification eliminated 99% of the 
protein in th e original extract (Table I). DE52 chromatography 
yielded a broad peak of phosphatase activity, eluting at 0.15 - 0.25 
M NaCI, which was often resolved into two peaks (Fig lA) . The 
second pea k could be identified as a protease that mimicked a phos-
phatase in th e precipitation assay, but cou ld be seen to completely 
degrade fil aggrin w hen the reaction mixtures were analyzed by 
SDS-PAGE (Fig 2). Profilaggrin phosphatase was partially resolved 
from acid phosphatase activity during the DE52 step. The re-
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Table I. Purification of Phosp hatase Acting on Filaggrin Phosphorylated by C K II 
Fraction Total protein (mg) T otal Activity U = tlmol PO. released/ min Specific Activi ty U/ mg Purification 
Initial extract 
DE 52 pool' 
Hydroxylapatite pool" 
S200 pools: 
170 kOa 
40 kOa 
• E stimated [NaCI] - 40 111M 
88.4 
23.0 
6.3 
1.8 
0. 9 
b Esti mated [sodium phosphate] = 25 mM. 
m a inder o f the ac id phosphatase activity and any remaining pro tease 
(resolutio n between the p rotease and the phosphatase w as no t al-
ways as complete as shown in Figs 1 and 2) w ere rem oved by hy-
droxy lapatIte chromatography (no t shown) , with the pro fil aggrin 
phosphatase elutingat 0.17 - 0.20 M phosphate . This step also sepa-
rat e d the profi laggnn phosphatase fro m the fila ggrin kinases [1 6]. 
Ana lysIs of recovery of phosphatase activity at each step was com-
plicated by th e presence of salt which inhibited th e ph osphatase 
activity, by phosphatase inhibitors in the original extract, and by the 
presence of proteases. R emoval of salt by dialysis destroyed the 
phosphatase activity; therefore, fractions w ere assayed by diluting 
the enz yme samples from each fraction (Table J). C orrection of th e 
tota l activ ity for the inhibition by salt w as not made , because the 
m agnitude of the effect depended o n the purity of the sample as w ell 
as the specific salt. The total activity detected after desalting during 
the final S200 step (Fig IB) w as 160% o f the activity detected in the 
initial extract, when assayed in the same salt conditions. This in-
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Figure 1. Chromatography of epidermal extract on OE52 (A) and S200 
(B). Chromatograph y and assay conditions are given in Methods. Protein 
ph osphatase activity is measured by release of32Pi from li laggrin phospho-
ry lated by CK II . A: Protein phosphatase activity, measured at pH 6.8 , is 
resolved from acid phosphatase, measured at pH 4.8, during the DE52 
chromatography. B: The protein phosphatase is resolved into two peaks by 
gel filtra tion. 0----0: profil aggrin phosphatase; +--+: acid phosphatase; 
• . . . .• : protein (0 0 ,80)' 
0.66 
0.58 
0.20 
0.52 
0.76 
0.0075 
0.025 
0.032 
0.23 
0.84 
o 
3 
33 
117 
crease w as even grea ter than apparent, because a) som e losses are 
expected durin g purificatio n , and b) a substantial am ount of the 
original activ ity w as due the protease activi ty w hich mimics a phos-
phatase in the precipitation assay. T he increase in to tal activity may 
be due to the rem oval of ph osphatase inhibitors (or possibly alterna-
tive substrates) during the purification . 
Characterization The protein phosphatase peak fro m hydrox-
y lapatite resolved into two peaks by S200 chromatography , one 
near the excluded volume (170 kOa) and one elut ing at 40 kOa (Fig 
1B). Other than m olecular w eight , the two form s were similar. 
They w ere bo th active tow ards phosphofil aggrin and p rofil aggrin , 
and no t active tow ards pNPP or phosphocasein. Various sm al l com -
pounds, including a number of phosphatase inhibitors, affected both 
in a similar m anner (Table II) . Activity of both forms was inhibited 
by N aCI with 50% inhibitio n at 25- 40 mM (Fi g 3). (T he small 
di ffe rence between the two curves is probably not signifi ca n t.) In 
additio n , bo th form s had the sam e pH o ptimum (Fig 4) . Only the 
170 kOa fo rm showed sig nificant changes in size in the presence of 
OTT. When pooled fractions fr0111 the S200 co lumn were rech ro-
m atographed 0 11 S300 in 1.0 111M OTT, both eluted in the same 
position (40 kOa, Fig 5). The change in elution of 170 kOa mig h t 
fi lo ggr in ~ ...... 
B 
fi loggr 
phospliota~e --------proteose 
Fig ure 2. SOS-PAGE and autorad iography of assays of OE52 fractions 
showing separation of phosphatase and protease activity. Fractions (number 
27 -55, fro m OE52 of Fig t A) were incubated with 7 pg phosphofilaggrin 
and analyzed by SOS-PAGE (7.5%-15% gradient gel). A: Coomassie-
stained ge l. B: Autoradiograph of A. LO ll es 4 through 7 show the radiolabel is 
removed, but the fil aggrin is intact, while falles 9 through 12 show complete 
proteolytic destruction of lilaggrin , mimicking phosphatase activity. Some 
DE52 fractions contain sufficient protein to be detected in the Coomassie-
stained gel (i .e., falle 4) . 
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Table II. Effect of Various Small Molecular Weight 
Compounds on Phosphatase Activity Toward Filaggrin 
Phosphorylated with CK II 
Activity Expressed 
as % of Control 
Compound Concentration (roM) 170 kDa 40 kDa 
DTT 10.0 151 139 
ZnClz 0.1 58 71 
CuClz 0.1 70 73 
CaCI2 0.1 11 2 125 
MgCI2 0.1 95 117 
MnCl, 0.1 95 101 
NaCI 0.1 101 98 
p-chloromercuribenzoate 0.01 11 10 
Sodium pyrophosphate 0.1 28 29 
NaF 0.1 44 41 
Na+ /K+ tartrate 0.1 64 78 
EDTA 0.1 100 100 
NaJVO. 0.1 104 105 
Ammonium Molybdate 0.1 107 102 
be due to breaking of disulfide linkages of an oligomer of 40 kDa, or 
to the dissociation of another, possibly regulatory, protein. 
Reducing SDS-PAGE of 170 and 40 kDa forms (Fig 6) showed 
several proteins in both the 170-kd fractio~ and the 40-~Da frac-
tion. There was a band at about 40 kDa 111 both fractions. We 
attempted to purify the phosphatase forms further by af!inity cllro-
matography on filaggrin Sepharose, by chromatofocus1l1g, and on 
phosphocellulose. In each case, the enzyme bound to the. re~in and 
was eluted, but activity declined rapidly to < ~O% Wlt~lI1 6 h . 
Therefore, additional studies were done on partlally punfied en-
zyme from the S200 step. 
Both forms of the phosphatase were tested toward (32PJ-profilag-
grin, labeled in vivo, to confirm thatthe use of the art.ificial substrate 
had yielded a phosphatase preparation that w.as active t?ward the 
natural substrate . Although this substrate was II1soluble, It could be 
suspended for assay, and both forms of the enzyme removed at least 
80% of the phosphate (Table III). Because of the insolubility, the 
substrate was difficult to pipet accurately, and the data were so 
variable that measurement of kinetic parameters was impossible. 
Neither form of the phosphatase removed radiolabel from casein 
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Figure 3. Inhibition of 170- and 40-kDa forms of profilaggrin phosphatase 
by NaC!. NaCI was added to the phosphatase assay at the final concentration 
shown. Substrate was lilaggrin phosphorylated by bovlIle CK /I (4230 cpm/ 
assay). Activity of samples is expressed as percent of cpm released 111 absence 
of added NaC!. 1200 cpm was released by the 170-kDa form and 980 cpm by 
the 40-kDa form in the absence of NaC/. O' .. 0: 170 kDa; +--+: 40 
kDa. 
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Figure 4. pH optima of the two phosphatase peaks from S200 dlromatog_ 
raphy. Ten microliters of each peak was incubated With lilaggnn phosph?_ 
rylated with CK II (27,880 cpm/assay) 111 50/1L with buller, as descnbed III 
Methods. After precipitation with 250 /1L ethanol, 200 ilL was counted . 
O· .. 0: 170-kDa peak; +--+: 40-kDa peak. 
phosphorylated by eK II, which includes several phosphoserine 
residues (14,22J. Both the 40- and 170-kDa phosphatase do not 
dephosphorylate a peptide substrate used for CK .II. (ar.gJ-glurthr_ 
gluJ ; see Ref 22) . To test whether this lack of actiVity IS due to the 
use of a peptide, rather than a protein s~bstrat~, phosphat~se was 
tested for its activity towards the tryptiC peptide contall1l11g the 
p'hosphate (F20, see Refs 16 and 10), as described in Methods. TI~e 
[npl-peptide was dephosphorylated With no apparent change ~n 
peak size, and the corresponding amount of radlOlabel appeared 111 
the unbound fractions where 32P j would be found. No other loss of 
peptide mass and no other alterations in the protein map were de-
tected. 
The acid phosphatases of epidermis were detected with pNPP at 
pH 4.8 and were resolved from the l?rofila~grin phosphatase during 
DE52 chromatography (Fig lA), 111 which the aCId phosphata~e 
activity eluted before the profilaggnn phosphatase. The protem 
phosphatase in the two S200 pools did not hydrolyze pNPP at pH 
4.8 or at pH 7.0. Both forms of the pro?lag~rin phosp~atase sho~ a 
pH optimum of pH 6.6 with little ac~lV1ty 111 the aCIdiC range (Fig 
4), unlike the previously described aCid phosphatases. 
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Figure 5. S300 chromatography of 40 and 170 kDa in reducing conditions. 
Eight milliliters of each phosphatase peak from the S200 column was c1uo-
matographed on S300 (1.6 cm X 80.5 cm); 1.2 mL. fractions were collected. 
Both forms of the phosphatase elute at the same position. O · . ,0: 170 kDa; 
+-+: 40 kDa. 
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Figure 6. SOS-PAGE of the 170 and 40-kOa forms from S200. A: Original 
extract; B: 170-kOa pool; c: 40-kOa pool. 0.5 mL of each pool was ethanol-
precipitated and the precipitate taken up in Laemmli sample buffer for 
SDS-PAGE on a 5%-15% gradient. The gel was stained with Coomassie 
blue. Low molecular weight and h igh molecu lar weight standards from 
Pharmacia were used to ca librate the gel. Arrows ind icate bands the 170 and 
40-kOa forms have in common. 
Preliminary investigation of the effect of ions and inhibitors at 
pH 6.8 on the extent of dephosphorylation is shown in Table II. 
Addition of DTT had the greatest ac tivating effect, while Ca+ 2 and 
Mg+2 alone were sli ghtly activating. Other metal ions were either 
inhibitory (Cu+2 and Zn+2) or without effect (Mn+2). The thiol 
reagent para-ch loromercuribenzoate was stron gly inhibitory, sug-
gesting a thiol is important to the enzyme activity . Some classical 
inhibitors of other phosphatases were effective, e.g., sodium 
pyrophosphate> sodium fluoride> N a,K tartrate, but ammonium 
molybdate and vanadate were ineffective . The inhibition by NaCI 
and N a phosphate was reversible (see above), because activity reap-
peaLed following gel filtration in a low-salt buffer. The effects of 
calcium are complex, because at acidic pH values, calcium inhibits 
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the enzyme (Table IV). This may be due to a shift in the pH opti-
mum toward higher pH in the presence of calcium, rather than 
alteration of Vnm• 
DISCUSSION 
W e have used fi laggrin phosphorylated by casein kinase II as a 
substrate to demonstrate the significant quantities of two protein 
phosphatases in epidermis, which appear to be two forms of the 
same enzyme, one 170 kDa and one 40 kDa. The two forms of the 
phosphatase have neutral pH optima, are strongly inhibited by 
N aCI, and show similar substrate specificity and activation and inhi-
bition by small compounds. Addition of Triton stabilizes their activ-
ity, but is not required for solubilization. The purified phosphatases 
are capable of dephosphorylating profilaggrin efficiently, and we 
have therefore identified it as profilaggrin phosphatase. 
Identification of this enzyme as a phosphatase, rather than a pro-
tease "mimic", was shown by SDS-PAGE of the dephosphorylated 
substrate. Although such an assay wou ld not be able to detect re-
moval of phosphate that was very near the amino- or carboxyl-ter-
minus, this could not have been the case in this situation. Peptide 
mapping has demonstrated that CK II labels mouse,filaggrin on the 
peptide F20 [16] at serine residues [9] known to be phosphorylated 
in vivo [10,16] . The sequence of a filaggrin domain from mouse has 
been published, which places the F20 phosphorylation sites 27 resi-
dues from the carboxyl-terminus [23]. Removal of these 27 residues 
wou ld alter the molecular weight 3.3 kD, which would be detected 
in our SDS-PAGE system. The sequence of a similar clone of rat 
profilaggrin shows the carboxyl-terminus region of rat and mouse 
are nearly identical. Phosphorylation of rat filaggrin with rat epi-
dermal CK II labels the peptide analogous to mouse F20. The phos-
phatase can dephosphorylate these phosphoserines both in intact 
protein and in the peptide F20. The dephosphorylation of peptide 
F20 occurs without detectable alteration of the HPLC peptide map-
ping profil e. Although it is not possible to rul e out specific proteoly-
sis of the F20 peptide (which would only be about 30% and might 
conceivably be n1.issed), it seems unlikely that only that peptide 
wou ld be degraded. 
T he profilaggrin phosphatase described here is specific, dephos-
phorylating profilaggrin and fi laggrin phosphorylated by CK II, but 
not casein or a small CK II-specific peptide phosphorylated by CK II. 
The inability to dephosphorylate the threonine of this CK II specific 
peptide suggests that profilaggrin phosphatase may be specific for 
serine, the residue which is phosphorylated in profilaggrin [9]. 
Profilaggrin phosphatase does not hydrolyze pNPP, unlike most 
well-characterized protein phosphatases [24]. A protein phospha-
tase that does not hydrolyze pNPP has been isolated from bo-
vine adrenal cortex [25], but differs from profilaggrin phosphatase 
in other properties. Donella-Deana et al [26] have isolated a protein 
phosphatase specific for sites phosphorylated by the casein kinases. 
However, profilaggrin phosphatase is more exacting in its substrate 
requirements, in that it does not dephosphorylate CK II sites in 
casein, or in the CK II-specific peptide. Most phosphoprotein phos-
phatases studied to date have been isolated using substrates phos-
phorylated by cAMP-dependent kinase (phosphorylase kinase, gly-
cogen synthase, pyruvate kinase, histones, protamine, casein, and 
phosphorylase a), and in general have been identified as multifunc-
Table III. Substrate Specificity of Profilaggrin Phosphatase' 
Substrate 
profibggrill' 
fi laggrind 
caseinli 
arg3 -gl u,- th r-g lu, d 
Total cpm Assayed" 
1,210 
40,700 
22,950 
67 ,762 
cpm Released by 170 kDa 
974 (80%) 
12,380 (30%) 
278 (1 %) 
933 (1%) 
cpm Relcased by 40 kOa 
1,040 (86%) 
8,960 (22%) 
526 (2%) 
1041 (1 %) 
cpm Released by Buffcr 
68 (6%) 
1,420 (3%) 
62 (.3%) 
530 (.5%) 
• Phosphory lated substrates were treated with each form of profilaggrill phosphatase for 30 mill, precipitated with ethanol, and the supernatant counted. 
b Profilaggrin, casein, and filaggrin were 10 till each; the peptide was 25 llil. The final volume during incubation with phosphatase was 255 llL. Assay conditions a.re given in 
Methods, 
C In vivo labeled, as described in MetJ,,,ds'
j 
d Labeled in vitro with CK II , as described in Me/h"d". 
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Table IV. Interaction of Calcium and pH on Phosphatase Measured with Filaggrin Phosphorylated by CK II' 
170 kDa 40 kDa 
pH No CaCl2 1 mM CaCl2 % C hange 
6.2 6400 ± 90 4069 ± 235 -36 
6.6 6800 ± 63 4670 ± 244 -31 
7.2 58 12 ± 400 5922 ± 109 +2 
'cpm released frol11 substrate (27.480 cpm tota l in assay) . 
tional phosphatases showing broad specificity [24 - 26]. The other 
sites of in vivo phosphorylation on profilaggrin appear to be phos-
phorylated by other nucleotide independent kinases [16]. It may be 
that phosphatases directed to sites phosphorylated by the nucleo-
tide-independent kinases are more specific than those phosphoryl-
ated by cAMP-dependent kinases [26] . The specificity strongly 
argues for a role of this enzyme in dephosphorylating profilaggrin 
111 VIVO. 
The dephosphorylation of the phosphofilaggrin substrate to no 
more than 30% in this study is of interest in the context of substrate 
specificity. We have recently noted that the total dephosphoryl-
ation achieved with phosphofilaggrin prepared with epidermal ki-
nases depends upon the pH of the phosphofilaggrin prior to addi-
tion of the phosphatase. Less 32Pi is released when the substrate is 
stored under basic conditions, as in this study where substrate was 
stored in water at pH> 9. In contrast, the profilaggrin was stored at 
neutral pH, in 1 M NaSCN, storage conditions which led to nearly 
complete dephosphorylation of phosphofilaggrin in our recent 
studies (see also Fig 2). Alternatively, the presence of other phos-
phorylated sites may influence the behavior of the enzyme and 
further study is necessary to understand this behavior. 
Previous studies of epidermal phosphatases have concentrated on 
the acid phosphatases, because their presence in high levels in gran-
ular cells suggested that lysosomal acid phosphatase are involved in 
the cellular degradation occurring at the time of keratinization [28]. 
However, 'previous attempts to dephosphorylate a large proteolytic 
fragment of profilaggrin with epidermal acid phosphatase were un-
successful [9]. Profilaggrin phosphatase is not similar to the epider-
mal acid phosphatases characterized by Frienkel and Traczyk [16], 
Makinen and Makinen (17), or Hara et al [18] . The major peak of 
acid phosphatase activity can be resolved from the profilaggrin 
phosphatase activity by ion exchange chromatography, and the par-
tially purified profilaggrin phosphatase does not hydrolyze pNPP at 
pH 4.8 or pH 7.0. Profilaggrin phosphatase shows a neutral pH 
optimum, while acid phosphatases have pH optima near 5. Because 
profilaggrin is a cytoplasmic component, a neutral pH optimum 
seems a more consistent property for a profilaggrin phosphatase. 
Other properties of the profilaggrin phosphatase that are consist-
ent with the proposed function are the effects of N aCI and the 
substrate specificity. Cells in the granular layer are thought to be 
undergoing a three- to fivefold and a two- to fivefold decrease in 
sodium and potassium, respectively, as they differentiate [29,30]. 
These changes could effectively regulate profilaggrin dephospho-
rylation, with decreasing sodium activating the phosphatase at the 
appropriate time. 
The significance of the two forms of the profilaggrin phosphatase 
is not cl ear. Treatment of the higher molecular weight form of the 
phosphatase with DTT causes it to co-elute with the 40-kDa en-
zyme, suggesting that the 40-kDa may be a subuni t of a larger 
complex. The active subunit of other phosphatases has been found 
to be 35 to 38 kDa (reviewed in Re(24), and the associated proteins 
are thought to have regulatory functions . It is tempting to speculate 
that the presence of phosphatase in an oxidized complex is relevant 
to the massive oxidation occuring as the cells undergo the transition 
to the cornified cel l [31] . Further work is needed to clarify whether 
the two interconvertible forms of the phosphatase have functional 
significance or are merely artifacts of homogenization. 
Phosphorylation may playa role in the interaction of filaggrin 
No CaCl2 1 tuM CaCl2 % C hange 
4591 ± 60 3250 ± 175 -30 
5622 ± 245 5069 ± 250 -10 
5413 ± 334 6136 ± 371 1+13 
and keratins [32]. Filaggrin and nonphosphoryl ated intermediates 
released during processing of profilaggrin to filaggrin are capable of 
interacting with keratins [33,34)' while profilaggrin is not. The 
major difference between the intermediates and profilaggrin is the 
absence of phosphate. Dephosphorylation of profilaggrin, allowing 
interaction of keratins with these multidomained filaggrins, must 
be a tightly controll ed event in the terminal differentiation of epi-
dermal cells, because premature aggregation of the keratin filaments 
would disrupt the cell's cytoskeleton. Studies of phosphorylation 
and dephosphorylation of epidermal structural proteins during the 
dramatic reorganization of the intermediate filaments during kera-
tinization may give us insight into the regulation of the intenne-
diate filament cytoskeleton. 
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